NLRP3 and non-small cell lung carcinoma: In order to investigate whether EEBR inhibits NSCLC progression in vivo via the NF‐κB‐NLRP3‐GSDMD pathway by promoting pyroptosis, we evaluated the levels of IL‐1β and IL‐18 in tumour tissues.